Prognostic and clinicopathological value of fibrinogen-to-albumin ratio in non-small cell lung cancer: a meta-analysis
OncologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- World journal of surgical oncology
- Publicado em
- 16 mai 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Prognostic and clinicopathological value of fibrinogen-to-albumin ratio in non-small cell lung cancer: a meta-analysis
Ling Tong, Hui Hu, Jiashan Li, Lihai Pan
Descritores MeSH
- Serum Albumin
- Biomarkers, Tumor
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Fibrinogen
- Survival Rate
- Humans
- Prognosis
Veja também
Estudos relacionados
- Prognostic and clinicopathological value of myeloid-derived suppressor cells in lung cancer: a comprehensive systematic review and meta-analysis
- Prognostic Value of Albumin-To-Fibrinogen Ratio and Fibrinogen and Albumin Score in Lung Cancer Patients: A Meta-Analysis
- The prognostic and clinicopathological value of HALP score in non-small cell lung cancer
- Predictive role of circulating tumor DNA based molecular residual disease for long-term outcomes in non-small cell lung cancer patients: a meta-analysis